Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials. (Q38000044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

positron emission tomography

27 January 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Antony Gee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Gary Cook

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Paul E. Kinahan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Vincent J. Cunningham

5

object named as

Vincent J Cunningham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

7

Dimitris Visvikis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Eric O Aboagye

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Ian N Fleming

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Ambros J Beer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Paul K Marsden

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Ashley M Groves

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Laura M Kenny

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Melvyn Myers

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Larry Clarke

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Experimental Cancer Medicine Centre 13 Imaging Network Group

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

4 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

1465-1478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22476502%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00330-011-2311-3

27 January 2020

exact match

0 references

cites work

Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Reproducibility of tumor perfusion measurements using 15O-labeled water and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Reproducibility of tumor blood flow quantification with 15O-water PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Using Positron Emission Tomography 2-Deoxy-2-[18F]Fluoro-D-Glucose, 11CO, and 15O-Water for Monitoring Androgen Independent Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

The relationship between vascular and metabolic characteristics of primary breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Complete radiological and metabolic response of metastatic renal cell carcinoma to SU5416 (semaxanib) in a patient with probable von Hippel-Lindau syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Serial PET scans demonstrate the success and limitations of antiangiogenic treatment in a case of lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

A new PET tracer specific for vascular endothelial growth factor receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Human dignity as a criterion for science policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Standards for PET image acquisition and quantitative data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Variability in PET quantitation within a multicenter consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

The progress and promise of molecular imaging probes in oncologic drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET.

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

21 January 2018

12 December 2020

Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Concurrent multimodality image segmentation by active contours for radiotherapy treatment planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

A gradient-based method for segmenting FDG-PET images: methodology and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Fully automated segmentation of oncological PET volumes using a combined multiscale and statistical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Quantitative imaging for evaluation of response to cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Respiratory motion in positron emission tomography/computed tomography: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

X-ray-based attenuation correction for positron emission tomography/computed tomography scanners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Improvement of the cine-CT based 4D-CT imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Pharmaceutical preparation of oxygen-15 labelled molecular oxygen and carbon monoxide gasses in a hospital setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2311-3

Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

21 January 2018

1 reference

12 December 2020

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.

1 reference

12 December 2020

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action

1 reference

12 December 2020

Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method

1 reference

12 December 2020

18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy

1 reference

12 December 2020

Reproducibility of metabolic measurements in malignant tumors using FDG PET

1 reference

12 December 2020

Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007

1 reference

12 December 2020

Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography.

1 reference

12 December 2020

Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

1 reference

12 December 2020

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

1 reference

12 December 2020

Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa

1 reference

12 December 2020

Oxygen-15 positron-emission tomography for predicting selective delivery of a chemotherapeutic agent to hepatic cancers during angiotensin II-induced hypertension

1 reference

12 December 2020

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

12 December 2020

Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography

1 reference

12 December 2020

Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients

1 reference

12 December 2020

The C15O2 build-up technique to measure regional cerebral blood flow and volume of distribution of water

1 reference

12 December 2020

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy

1 reference

12 December 2020

Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding

1 reference

12 December 2020

Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients

1 reference

12 December 2020

Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues

1 reference

12 December 2020

PET of vascular endothelial growth factor receptor expression.

1 reference

12 December 2020

Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra-abdominal cancers.

1 reference

12 December 2020

The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomas.

1 reference

12 December 2020

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

Angiotensin-II-induced hypertension chemotherapy: evaluation of hepatic blood flow with oxygen-15 PET

1 reference

12 December 2020

In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck

1 reference

12 December 2020